Department of Biomedical Engineering, University of Connecticut, Storrs, CT, USA; Department of Orthopaedic Surgery, University of Connecticut Health, Farmington, CT, USA.
Department of Orthopaedic Surgery, University of Connecticut Health, Farmington, CT, USA.
J Control Release. 2019 Feb 28;296:54-67. doi: 10.1016/j.jconrel.2019.01.013. Epub 2019 Jan 15.
Peripheral nerve injury accounts for roughly 2.8% of all trauma patients with an annual cost of 7 billion USD in the U.S. alone. Current treatment options rely on surgical intervention with the use of an autograft, despite associated shortcomings. Engineered nerve guidance conduits, stem cell therapies, and transient electrical stimulation have reported to increase speeds of functional recovery. As an alternative to the conduction effects of electrical stimulation, we have designed and optimized a nerve guidance conduit with aligned microchannels for the sustained release of a small molecule drug that promotes nerve impulse conduction. A biodegradable chitosan structure reinforced with drug-loaded halloysite nanotubes (HNT) was formed into a foam-like conduit with interconnected, longitudinally-aligned pores with an average pore size of 59.3 ± 14.2 μm. The aligned composite with HNTs produced anisotropic mechanical behavior with a Young's modulus of 0.33 ± 0.1 MPa, very similar to that of native peripheral nerve. This manuscript reports on the sustained delivery of 4-Aminopyridine (4AP, molecular weight 94.1146 g/mol), a potassium-channel blocker as a growth factor alternative to enhance the rate of nerve regeneration. The conduit formulation released a total of 30 ± 2% of the encapsulated 4AP in the first 7 days. Human Schwann cells showed elevated expression of key proteins such as nerve growth factor, myelin protein zero, and brain derived neurotrophic factor in a 4AP dose dependent manner. Preliminary in vivo studies in a critical-sized sciatic nerve defect in Wistar rats confirmed conduit suturability and strength to withstand ambulatory forces over 4 weeks of their implantation. Histological evaluations suggest conduit biocompatibility and Schwann cell infiltration and organization within the conduit and lumen. These nerve guidance conduits and 4AP sustained delivery may serve as an attractive strategy for nerve repair and regeneration.
周围神经损伤占美国所有创伤患者的 2.8%左右,每年的治疗费用高达 70 亿美元。目前的治疗选择依赖于使用自体移植物的手术干预,尽管存在相关的缺点。工程神经引导导管、干细胞疗法和短暂电刺激已被报道能提高功能恢复速度。作为电刺激传导作用的替代方法,我们设计并优化了一种带有对齐微通道的神经引导导管,用于持续释放一种促进神经冲动传导的小分子药物。一种用载药埃洛石纳米管(HNT)增强的可生物降解壳聚糖结构被制成一种泡沫状导管,具有相互连接的、沿纵向对齐的孔,平均孔径为 59.3±14.2μm。具有 HNTs 的对齐复合材料产生各向异性的机械行为,杨氏模量为 0.33±0.1MPa,与天然周围神经非常相似。本文报告了持续释放 4-氨基吡啶(4AP,分子量 94.1146g/mol),作为替代生长因子的钾通道阻滞剂,以提高神经再生速度。导管配方在最初的 7 天内总共释放了 30±2%的包裹 4AP。人雪旺细胞在 4AP 剂量依赖性方式下表现出关键蛋白如神经生长因子、髓鞘蛋白零和脑源性神经营养因子的高表达。在 Wistar 大鼠的临界尺寸坐骨神经缺损的初步体内研究中,证实了导管的可缝合性和强度,能够承受植入后 4 周的步行力。组织学评估表明导管具有生物相容性和雪旺细胞在导管和管腔中的浸润和组织。这些神经引导导管和 4AP 持续释放可能成为神经修复和再生的有吸引力的策略。